Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Motor Activity 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Body Weight 1

Interventions

Gemcitabine 25 Cisplatin 19 pembrolizumab 11 avelumab 10 Nivolumab 7 Mitomycin 6 Carboplatin 6 apaziquone 5 Paclitaxel 5 Vinblastine 4 Methotrexate 4 Doxorubicin 4 Docetaxel 4 BCG Vaccine 4 vofatamab 3 durvalumab 3 atezolizumab 3 Sunitinib 3 Standard of Care 3 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Lapatinib 3 Cystectomy 3 B701 protein, Human herpesvirus 6 3 valrubicin 2 rucaparib 2 enfortumab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Urinary Bladder Neoplasms × Diet Therapy × Clear all

NCT03286699 2025-01-10

LCBH

University of Pittsburgh

Phase NA Terminated

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡